Literature DB >> 15737693

Frequent mutation related with overexpression of DNA polymerase beta in primary tumors and precancerous lesions of human stomach.

Xiao-Hui Tan1, Min Zhao, Kai-Feng Pan, Ying Dong, Bin Dong, Gui-Jian Feng, Guang Jia, You-Yong Lu.   

Abstract

To explore whether DNA polymerase beta (pol beta) contributes to the malignant transformation of gastric mucosa, we examined pol beta in gastric tumor cell lines, primary tumors and precancerous lesions. Point mutations of pol beta were detected in 6 of 13 cell lines and 23 of 104 tissues including 35.0% (14/40) of gastric cancer (GC), 30.0% (3/10) of dysplasia (Dys), 28.6% (4/14) of intestinal metaplasia (IM) and 10.5% (2/19) of chronic atrophic gastritis (CAG), respectively. A frequent mutation was a T to C transition at nucleotide 889, which was observed in 4 GC cell lines, 7 GC, 2 Dys, and 2 IM. The level of pol beta expression in tumors was higher than that of their matched normal tissues and gradual changes from GC, Dys, CAG to IM. These results indicate that the mutation and overexpression of pol beta may influence the progression during gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737693     DOI: 10.1016/j.canlet.2004.07.049

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Characterization of DNA polymerase beta splicing variants in gastric cancer: the most frequent exon 2-deleted isoform is a non-coding RNA.

Authors:  Valeria Simonelli; Mariarosaria D'Errico; Domenico Palli; Rajendra Prasad; Samuel H Wilson; Eugenia Dogliotti
Journal:  Mutat Res       Date:  2009-07-25       Impact factor: 2.433

2.  I260Q DNA polymerase β highlights precatalytic conformational rearrangements critical for fidelity.

Authors:  Cary Liptak; Mariam M Mahmoud; Brian E Eckenroth; Marcus V Moreno; Kyle East; Khadijeh S Alnajjar; Ji Huang; Jamie B Towle-Weicksel; Sylvie Doublié; J Patrick Loria; Joann B Sweasy
Journal:  Nucleic Acids Res       Date:  2018-11-16       Impact factor: 16.971

3.  DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment.

Authors:  Tao Wang; Wenqiao Zang; Yunyun Ma; Min Li; Xiaoyan Xuan; Na Wang; Rui Wu; Yuebai Li; Ziming Dong; Guoqiang Zhao
Journal:  Mol Biol Rep       Date:  2012-11-03       Impact factor: 2.316

4.  Involvement of DNA polymerase β overexpression in the malignant transformation induced by benzo[a]pyrene.

Authors:  Wei Zhao; Mei Wu; Yanhao Lai; Wenwen Deng; Yuan Liu; Zunzhen Zhang
Journal:  Toxicology       Date:  2013-05-04       Impact factor: 4.221

5.  DNA damage tolerance: a double-edged sword guarding the genome.

Authors:  Gargi Ghosal; Junjie Chen
Journal:  Transl Cancer Res       Date:  2013       Impact factor: 1.241

6.  Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation.

Authors:  Joann B Sweasy; Tieming Lang; Daniela Starcevic; Ka-Wai Sun; Char-Chang Lai; Daniel Dimaio; Shibani Dalal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-22       Impact factor: 11.205

7.  DNA polymerase β mutations and survival of patients with esophageal squamous cell carcinoma in Linzhou City, China.

Authors:  Min Li; Wenqiao Zang; Yuanyuan Wang; Yunyun Ma; Xiaoyan Xuan; Jimin Zhao; Lulu Liu; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-01

Review 8.  DNA polymerases and cancer.

Authors:  Sabine S Lange; Kei-ichi Takata; Richard D Wood
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

9.  Involvement of p38MAPK-ATF2 signaling pathway in alternariol induced DNA polymerase β expression.

Authors:  Jimin Zhao; Junfen Ma; Jing Lu; Yanan Jiang; Yanyan Zhang; Xiaoyan Zhang; Jun Zhao; Hongyan Yang; Youtian Huang; Mingyao Zhao; Kangdong Liu; Ziming Dong
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

10.  Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.

Authors:  Ram N Trivedi; Xiao-hong Wang; Elena Jelezcova; Eva M Goellner; Jiang-bo Tang; Robert W Sobol
Journal:  Mol Pharmacol       Date:  2008-05-13       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.